Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03095352
Title Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hope Rugo, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco San Francisco California 94143 United States Details
Georgetown University Hospital Washington District of Columbia 20007 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field